Location: Home> Products> Star Products
Click to return to the list
Common name: Doxorubicin Hydrochloride Liposomal Injection
English name: Doxorubicin Hydrochloride Liposome Injection
Approval number: National Pharmaceutical Standard H20113320 / H20163178
Specification: 10ml: 20mg / 5ml: 10mg
Indications: This product can be used as first-line systemic chemotherapy drugs, or as second-line chemotherapy drugs for patients with progressive AIDS-KS, or for patients who cannot tolerate the combination of two or more of the following drugs: vincristine Bleomycin and doxorubicin (or other anthracycline antibiotics). The guidelines are recommended for the treatment of ovarian cancer, lymphoma, multiple myeloma, breast cancer, uterine tumors, and bone and soft tissue sarcomas.